Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed from the history; these administrative updates do not modify trial data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site-wide notice about government funding and operating status was removed from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedNew history entries were added to the record, but core study data and page structure remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 version release, replacing the old v3.1.0.SummaryDifference9%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision updated to v3.0.2 (from v3.0.1); the 'Back to Top' element was removed; otherwise core content remains unchanged.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.